Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06390059
Status:
RECRUITING
Last Update Posted:
2024-05-03
First Post:
2024-02-29
Brief Title:
EF-39 PANOVA-4 Study of Tumor Treating Fields Concomitant With Atezolizumab Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma
Sponsor:
NovoCure GmbH
Organization:
NovoCure Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-28
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-29
First Submit QC Date:
April 26 2024
Study First Post Date:
2024-04-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-02
Last Update Post Date:
2024-05-03
Last Update Post Date Type:
ACTUAL